International conferences - Advanced Technologies & Treatments for Diabetes

1. 1. ATTD, 13th International Conference, Madrid, Spain, Feb 19-22, 2020.
2. Utility of a Glucose meter with Bluetooth and Web Connectivity in Aiding Physicians and Patients Achieve Better Glycemic Levels. Kesavadev J, Krishnan G, Shankar A, Ashok A, Shamsudeen J, Thampiraj K, Manu A, Jothydev S. Diabetes Technol Ther. 2020 Feb.22(S1). A109. Link 1 | Link 2
3. Outlining the Relationship Between Time In Target (TIT) and HbA1c in Asian Indians with Diabetes. Kesavadev J, Shankar A, Warrier R, Krishnan G, Shamsudeen J, Jothydev S. Diabetes Technol Ther. 2020 Feb. 22(S1). A131. Link 1 | Link 2
4. 2. ATTD, 12th International Conference, Berlin, Germany, Feb 20-23, 2019.
5. Harnessing the Power of Social Media for a Structured and Instant Intervention, Education and Counselling in Type 1 Diabetes. Kesavadev J, Shankar A, David A, Sanal G, Ajith J, Krishnan G, Ramachandran L, Jothydev S. Diabetes Technol Ther. 2019 Feb. 21. A116. Link 1 | Link 2 | Link 3
6. Assessing the Benefits of a Painless Lancing Device in a Subset of Patients Fearful of Finger Pricking. Warrier R, Badarudeen S, Shankar A, Krishnan G, Ramachandran L, Thampiraj K, Jothydev S, Kesavadev J. Diabetes Technol Ther. 2019 Feb. 21. A60-A61. Link 2 | Link 2 | Link 3
7. 3. ATTD, 11th International Conference, Austria, Feb 14-17, 2018.
8. SMBG and virtual consultation via DTMS®: 20 years' experience. Invited Lecture: Dr. Jothydev Kesavadev. Diabetes Technol Ther. 2018 Feb. 20(S1). A5-A6. Link 1 | Link 2
9. Patient and caregiver feedback on the first generation Artificial Pancreas in India. Kesavadev J, Ramachandran L, Shankar A, David A, Jose R, Anilkumar A L, Krishnan G, Jothydev S. Diabetes Technol Ther.2018 Feb. 20(S1). A55-A56.
   Link 1 | Link 2
10. Utility of a multi-model bot enabled, and doctor led intervention for diabetes management- clinician and patient perspectives. Kesavadev J, Saboo B, Ramachandran L, Shankar A, David A, Krishnan G, Jothydev S. Diabetes Technol Ther.2018 Feb. 20(S1).A39- A40. Link 1 | Link 2
11. Diabetes duration-based initiation of insulin: impact on clinical outcomes, insulin dosage and quality of life. Kesavadev J, Saboo B, Shankar A, David A, Jothydev K, Ramachandran L, Krishnan G, Jothydev S. Diabetes Technol Ther. 2018 Feb. 20(S1). A149-A150. Link 1 | Link 2
12. Effectiveness of a digital therapeutic for improving outcomes in South Asians living with type-2 diabetes - results from an ongoing real-world pilot trial. Saboo B, Shaikh M, Shah A, Sosale A, Kesavadev J, Chawla M, Makkar B M, Kovil R, Chawla R, Bajaj S. Diabetes Technol Ther. 2018 Feb. 20(S1). A79-A80. Link 1 | Link 2
13. 4. ATTD, 10th International Conference, Paris, Feb 15-18, 2017.
14. Is Cancer Screening in Diabetes Justified? Insights from Electronic Medical Records. Kesavadev J, Shankar A, Ramachandran L, Krishnan G, Jothydev S. Diabetes Technol Ther.2017 Feb. 19(S1). A1-A133. Read More
15. Better Outcomes in Type 2 Diabetes Management with a User Friendly Flash Glucose Monitoring System: Freestyle Libre Pro. Kesavadev J, Krishnan G, Saboo B, Shankar A, Ashok AD, Sanal G, Ramachandran L, Jothydev S. Diabetes Technol Ther. 2017 Feb.19(S1).A1-A133. Read More
16. 5. ATTD, 9th International Conference, Milan, Italy, Feb 3-6, 2016.
17. Periodic follow up with telemanagement system for 15 years and significant reduction in vascular complications in T2DM. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Diabetes Technol Ther. 2016 Feb. 18(S1). A92-A-93.
    Link 1 | Link 2 | Link 3
18. Comparing IPRO with Libre for Sensor Accuracy and User Friendliness. Kesavadev J, Shankar A, Sanal G, Krishnan G, Jothydev S, Pillai P. B. Diabetes Technol Ther. 2016 Feb. 18(S1). A74. Link 1 | Link 2 | Link 3
19. Extending Metformin Benefits in Patients with Type 2 Diabetes through Pill Technology: A Systematic Review of Nine Pooled Clinical Trials. Kumar S, Gupta S, Kumar A, Tiwaskar M, Sharma S, Kesavadev J, Thacker H, Wadhwa N, editors. Diabetes Technol Ther. 2016 Feb. 18(S1). A130-A131. Link 1 | Link 2
20. 6. ATTD, 8th International Conference,Paris, France, Feb 18-21, 2015.
21. Role of Home Blood Pressure Monitoring in Halting the Progression of Diabetic Kidney Disease: 6 Year Follow up Data. Kesavadev J, Joshi S, Saboo B, Shankar A, Pillai P. S, Sanal G, Jothydev S. Diabetes Technol Ther. 2015. 17. A123.
    Read More
22. Impact of Insulin Pump Therapy on Erectile Dysfunction in Type 2 Diabetes. Kesavadev J, Pillai P. S, Shankar A, Jothydev S. Diabetes Technol Ther. 2015. 17. A40. Read More
23. 7. ATTD, 7th International Conference, Vienna, Austria,Feb 4-5, 2014.
24. Use of Insulin Pumps in T2DM in India: Merits and Demerits learnt over a decade. Invited Speaker. Advanced Technologies and Treatments for Diabetes (ATTD), Vienna, Austria 2014. O-86. Diabetes Technol Ther. 2014 Feb. 16(S1): A-1-A-162. Read More
25. Clinical utility of cgm in pre-diabetes and its impact on modifying lifestyles. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes Technol Ther. 2014. 16. A41. P-106. Diabetes Technol Ther. 2014 Feb; 16(S1): A-1-A-162.
    Link 1 | Link 2
26. Live brief weekly educational questionnaire via DTMS® as a tool to improve the acceptability and outcome in type 2 diabetes. Kesavadev J, Shankar A, Sanal G, Lally J, Krishnan G, Jothydev S. Diabetes Technol Ther. 2014 Feb. 16(S1). A115-A116. P- 295. Read More
27. Use of Ipro2 in Real-Life Management of Type 2 Diabetes Patients In India. Mohan V, Kesavadev J, Jain S. M, Chawla M, Mutha A, Saboo B, Kovil R, Viswanathan V, Mithal A Punatar D, Shaikh, S, Shin J. P-311. Diabetes Technol Ther. 2014 Feb. 16(S1): A-1-A-162. Read More
28. 8. ATTD, 6th International Conference, Paris, France, Feb 27- Mar 2, 2013.
29. Attitudes and Behaviour Of Type 2 Diabetes Patients on Insulin Pumps. Kesavadev J, Shankar A, Krishnan G, Jothydev S. Diabetes Technol Ther. 2013 Feb. 15(S1). A43- A44. Link 1 | Link 2 | Link 3
30. Glycemic Variability in Type 2 Diabetes Correlates with Total Daily Dose of Insulin And Use of Sulfonlyureas. Kesavadev J, Pillai P. B. S, Shankar A, Krishnan G, Jothydev S.Diabetes Technol Ther. 2013 Feb. 15(S1). A-66.
    Link 1 | Link 2 | Link 3
31. 9. ATTD, 5th International Conference, Barcelona, Spain, Feb 11-12, 2012.
32. Acceptance of Continuous Glucose Monitoring (CGM) as a Routine Investigation in Diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Lally J, Sanal G, Jothydev S.Diabetes Technol Ther. 2012 Feb. 14(19). Read More
33. Geographical location and effectiveness of a simple telemedicine program (DTMS®) in diabetes. Kesavadev J, Pillai P. B. S, Shankar A, Gopalakrishnan G, Lally J, Jothydev S. Diabetes Technol Ther. 2012 Feb. 14(19). Read More
34. 10. ATTD, 4th International Conference,London, UK,Feb 16-19, 2011.
35. CGM as a tool For Therapeutic Decision Making (TDM) In Type 2 Diabetes Mellitus. Kesavadev J, Babu P, Gopalakrishnan G,Jothydev S. P-108. Read More
36. Pregnancy, Wolfram Syndrome and Insulin Pump: benefits beyond glycemic control. Kesavadev J, Kumar A, Shankar A, Gopalakrishnan G, Jothydev S.P-109. Read More
37. 11. ATTD, 3rd International Conference, Basel, Switzerland, Feb 10-13, 2010.
38. Significant Alleviation of Neuropathic Pain with Insulin Pumps (CSII) in T2DM subjects previously on MDI. Kesavadev J, Shamsudeen J, Shankar A, Gopalakrishnan G, Satheesh J, Jothydev S. Read More
39. 12. ATTD, 2nd International Conference, Greece, Athens, Feb 25-28, 2009.
40. Reasons for non-compliance to Diabetes Tele Medicine Based Follow up Program in Type 2 Diabetes.
41. Insulin Pump in 56 Type 2 diabetes subjects: Improvement of sexual satisfaction and neuropathic symptoms.